FEASIBILITY & ENVIRONMENTAL ASESSMENT
The first step for connecting rare disease patients to orphan drugs therapies is to understand its value-chain and the involved stakeholders. OrphanDC offers a tailor-made Feasibility & Environmental Assessment service, focused on providing an integrated process for trial acceleration with the best environment for our clients’ performance.
Picture3.png
Picture4.png
Picture7.png

Hematology

 

Nephrology

 

Oncology

 

Ophthalmology

Picture8.png

Pneumonology

 

Neurology 

 

COVID-19